Department of Vascular Surgery, University College Hospital Galway, Newcastle Road, Dublin 8, Dublin, H91YR71, Ireland.
School of Medicine, University of Galway, Galway, Ireland.
Ir J Med Sci. 2023 Dec;192(6):3007-3010. doi: 10.1007/s11845-023-03362-1. Epub 2023 Apr 26.
Symptomatic peripheral arterial disease (PAD) is a common cause for referral from primary care to vascular surgery. Best medical therapy (BMT), encompassing anti-platelets, statins, smoking cessation, blood pressure and glycaemic control, is a cornerstone of PAD management. However, these easily modifiable risk factors are often left unaddressed between referral and clinic review.
A prospective audit of electronic 'Healthlink' referrals by GPs to the vascular department for symptomatic PAD between July 2021 and June 2022 was performed. Referrals were individually reviewed for demographics, symptoms, medical history, smoking status and medications. An information leaflet on BMT was posted to all GP practices in the Soalta region as part of an educational intervention, with plans to re-audit after 6 months.
One-hundred-and-seventy referrals were analysed. The median age was 68.5 years (range 33-94) and 69% (n = 117) were male. The typical vasculopath comorbidity profile was noted. Fifty-two percent (n = 88) were referred with claudication-type pain and 25% (n = 43) with critical limb ischaemia (CLI). Twenty-eight percent (n = 33) were active smokers and 31% (n = 36) had no smoking status documented. Regarding BMT, only 34.5% (n = 40) and 52% (n = 60) were on anti-platelets and statins, respectively. Suspected CLI was not significantly associated with BMT prescription at referral (p = 0.664). Only eleven referral letters mentioned risk factor optimisation.
Our first-cycle results identified significant scope for improvement in community-based risk factor modification for PAD referrals. We aim to continue supporting and educating our colleagues that effective medical management can start safely in primary care and further explore the barriers preventing this.
有症状的外周动脉疾病(PAD)是从初级保健向血管外科转诊的常见原因。最佳药物治疗(BMT)包括抗血小板药物、他汀类药物、戒烟、血压和血糖控制,是 PAD 管理的基石。然而,这些易于改变的危险因素在转诊和临床复查之间往往得不到解决。
对 2021 年 7 月至 2022 年 6 月期间,全科医生通过电子“Healthlink”向血管科转诊的有症状 PAD 的患者进行了前瞻性审核。对转诊患者的人口统计学、症状、病史、吸烟状况和药物使用情况进行了单独审查。作为教育干预的一部分,向索尔塔地区的所有全科医生诊所发放了一份关于 BMT 的信息传单,并计划在 6 个月后重新审核。
共分析了 170 份转诊记录。中位年龄为 68.5 岁(范围 33-94 岁),69%(n=117)为男性。注意到典型的血管病变合并症谱。52%(n=88)因跛行性疼痛而转诊,25%(n=43)因严重肢体缺血(CLI)而转诊。28%(n=33)为现吸烟患者,31%(n=36)的吸烟状况未记录。关于 BMT,分别只有 34.5%(n=40)和 52%(n=60)的患者接受了抗血小板和他汀类药物治疗。疑似 CLI 与转诊时 BMT 处方无显著相关性(p=0.664)。只有 11 封转诊信提到了危险因素优化。
我们的第一轮结果发现,在社区为 PAD 转诊患者进行危险因素改变方面有很大的改进空间。我们旨在继续支持和教育我们的同事,安全地在初级保健中开始有效的药物治疗,并进一步探索阻碍这一治疗的因素。